HRT Financial’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
HRT Financial's MTRI Position: Q4 2024 in Review
HRT Financial sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2024, closing a stake of 192 shares — an estimated $8K sold.
HRT Financial first reported a position in MTRI in Q2 2024 and held it in 2 quarters. The position peaked at $8K in Q3 2024. 2 funds tracked by Wall St. Rank hold MTRI as of Q4 2024.
- HRT Financial reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- HRT Financial sold 192 Mentari Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $8K.
- HRT Financial first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
- HRT Financial's Mentari Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2024.
Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.